Robitaille Julie, Denslow Nancy D, Escher Beate I, Kurita-Oyamada Hajime G, Marlatt Vicki, Martyniuk Christopher J, Navarro-Martín Laia, Prosser Ryan, Sanderson Thomas, Yargeau Viviane, Langlois Valerie S
Centre Eau Terre Environnement, Institut National de La Recherche Scientifique (INRS), Quebec City, QC, Canada.
University of Florida, Gainesville, FL, United States.
Environ Res. 2022 Apr 1;205:112483. doi: 10.1016/j.envres.2021.112483. Epub 2021 Dec 2.
Endocrine disrupting chemicals (EDCs) are found in every environmental medium and are chemically diverse. Their presence in water resources can negatively impact the health of both human and wildlife. Currently, there are no mandatory screening mandates or regulations for EDC levels in complex water samples globally. Bioassays, which allow quantifying in vivo or in vitro biological effects of chemicals are used commonly to assess acute toxicity in water. The existing OECD framework to identify single-compound EDCs offers a set of bioassays that are validated for the Estrogen-, Androgen-, and Thyroid hormones, and for Steroidogenesis pathways (EATS). In this review, we discussed bioassays that could be potentially used to screen EDCs in water resources, including in vivo and in vitro bioassays using invertebrates, fish, amphibians, and/or mammalians species. Strengths and weaknesses of samples preparation for complex water samples are discussed. We also review how to calculate the Effect-Based Trigger values, which could serve as thresholds to determine if a given water sample poses a risk based on existing quality standards. This work aims to assist governments and regulatory agencies in developing a testing strategy towards regulation of EDCs in water resources worldwide. The main recommendations include 1) opting for internationally validated cell reporter in vitro bioassays to reduce animal use & cost; 2) testing for cell viability (a critical parameter) when using in vitro bioassays; and 3) evaluating the recovery of the water sample preparation method selected. This review also highlights future research avenues for the EDC screening revolution (e.g., 3D tissue culture, transgenic animals, OMICs, and Adverse Outcome Pathways (AOPs)).
内分泌干扰化学物质(EDCs)存在于每一种环境介质中,且化学性质多样。它们在水资源中的存在会对人类和野生动物的健康产生负面影响。目前,全球范围内对于复杂水样中EDC水平没有强制性的筛查要求或规定。生物测定法可用于量化化学物质的体内或体外生物学效应,常用于评估水中的急性毒性。现有的经合组织(OECD)识别单一化合物EDC的框架提供了一组针对雌激素、雄激素、甲状腺激素以及类固醇生成途径(EATS)进行验证的生物测定法。在本综述中,我们讨论了可能用于筛查水资源中EDC的生物测定法,包括使用无脊椎动物、鱼类、两栖动物和/或哺乳动物物种的体内和体外生物测定法。讨论了复杂水样样品制备的优缺点。我们还回顾了如何计算基于效应的触发值,该值可作为阈值,根据现有质量标准确定给定水样是否构成风险。这项工作旨在协助各国政府和监管机构制定一项针对全球水资源中EDC监管的测试策略。主要建议包括:1)选择经过国际验证的细胞报告基因体外生物测定法,以减少动物使用和成本;2)在使用体外生物测定法时测试细胞活力(一个关键参数);3)评估所选水样制备方法的回收率。本综述还强调了EDC筛查革命的未来研究方向(例如,3D组织培养、转基因动物、组学和不良结局途径(AOPs))。